Skip to main content

Iridex Corp

IRIX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001006045

In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Iridex Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of IRIX: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders3329−4
Shares3.85M3.50M−357.2K (−9.3%)
Value$27.2M$26.8M−$424.9K (−1.6%)

New holders (5)

Institutions that held Iridex Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to IRIX in Q3 2021
InstitutionSharesValue% of portfolio
Blair William & Co75,000$575.0K0.00%
Bank of New York Mellon Corp34,693$266.0K0.00%
Susquehanna International Group, LLP10,923$84.0K0.00%
Conservest Capital Advisors, Inc.10,268$79.0K0.01%
Total Clarity Wealth Management, Inc.2,037$16.0K0.01%

Sold out (9)

Institutions that held Iridex Corp at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of IRIX in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Invenomic Capital Management LP156,395$1.10M
EAM Investors, LLC145,805$1.03M
Raymond James & Associates26,743$189.0K
StoneX Group Inc.19,575$138.0K
PDT Partners, LLC14,732$104.0K
Citadel Advisors LLC13,104$92.0K
Trexquant Investment LP11,479$81.0K
Northwestern Mutual Wealth Management Co125$1.00K
Bank of America Corp29$0